Literature DB >> 25817149

Categorization of bladder dynamics and treatment after fetal myelomeningocele repair: first 50 cases prospectively assessed.

Marcela Leal da Cruz1, Riberto Liguori2, Gilmar Garrone2, Bruno Leslie2, Sérgio Leite Ottoni2, Sérgio Carvalheiro3, Antonio Fernandes Moron4, Valdemar Ortiz2, Antonio Macedo2.   

Abstract

PURPOSE: We categorized bladder patterns and principles of treatment applied to patients who underwent myelomeningocele repair during gestation in a prospective urological assessment.
MATERIALS AND METHODS: We performed urinary tract ultrasound, voiding cystourethrogram and urodynamic evaluation. We then categorized patients into 4 patterns, including normal, high risk (overactive bladder with detrusor leak point pressure greater than 40 cm H2O and high filling pressure also greater than 40 cm H2O), incontinent and underactive bladder.
RESULTS: A total of 51 patients were enrolled in study at the first medical appointment. Urodynamic evaluation was done in 48 of these patients as the initial investigation, enabling attribution of a bladder pattern. The high risk pattern was found in 27 patients (56.2%), 18 were incontinent and 1 had an underactive bladder. Only 2 patients (4.2%) in this series had a normal bladder.
CONCLUSIONS: Of patients who underwent myelomeningocele closure during gestation 93.7% had significant lower urinary tract dysfunction consisting of high bladder pressure or incontinence. These data reinforce the absolute need to follow these patients closely. The potential benefits of fetal surgery in the urinary tract remain to be proved.
Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  fetal therapies; meningomyelocele; neurogenic; risk; urinary bladder; urodynamics

Mesh:

Year:  2015        PMID: 25817149     DOI: 10.1016/j.juro.2014.10.118

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

Review 1.  Neuropathic bladders: Investigation and treatment through their lifetime.

Authors:  Peter D Metcalfe
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

Review 2.  Fetal surgery: a critical review.

Authors:  H Kitagawa; K C Pringle
Journal:  Pediatr Surg Int       Date:  2017-01-05       Impact factor: 1.827

Review 3.  Urological Outcomes of Myelomeningocele and Lipomeningocele.

Authors:  Yvonne Y Chan; Samantha K Sandlin; Eric A Kurzrock
Journal:  Curr Urol Rep       Date:  2017-05       Impact factor: 3.092

4.  Low level myelomeningoceles: do they need prenatal surgery?

Authors:  Pierre-Aurelien Beuriat; Isabelle Poirot; Frederic Hameury; Delphine Demede; Kieron J Sweeney; Alexandru Szathmari; Federico Di Rocco; Carmine Mottolese
Journal:  Childs Nerv Syst       Date:  2019-03-27       Impact factor: 1.475

Review 5.  Fetoscopy for meningomyelocele repair: past, present and future.

Authors:  Nicole Silva Bevilacqua; Denise Araujo Lapa Pedreira
Journal:  Einstein (Sao Paulo)       Date:  2015 Apr-Jun

Review 6.  Antenatal management of fetal neurosurgical diseases.

Authors:  Sergio Cavalheiro; Marcos Devanir Silva da Costa; Jardel Nicacio Mendonça; Patricia Alesssandra Dastoli; Italo Capraro Suriano; Mauricio Mendes Barbosa; Antonio Fernandes Moron
Journal:  Childs Nerv Syst       Date:  2017-05-29       Impact factor: 1.475

7.  In utero myelomeningocele repair and high-risk bladder pattern. a prospective study.

Authors:  Antonio Macedo; Sérgio Leite Ottoni; Antonio Moron; Sergio Cavalheiro; Marcela Leal da Cruz
Journal:  Int Braz J Urol       Date:  2022 Jul-Aug       Impact factor: 3.050

Review 8.  The Management of the Pediatric Neurogenic Bladder.

Authors:  Renea M Sturm; Earl Y Cheng
Journal:  Curr Bladder Dysfunct Rep       Date:  2016-07-02

9.  Study of serum and urinary markers of the renin-angiotensin-aldosterone system in myelomeningocele patients with renal injury detected by DMSA.

Authors:  Cássia Maria Carvalho Abrantes do Amaral; Dulce Elena Casarini; Maria Cristina Andrade; Marcela Leal da Cruz; Antônio Macedo
Journal:  Int Braz J Urol       Date:  2020 Sep-Oct       Impact factor: 3.050

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.